Evaluation of the predictive value of the HFA-ICOS score for cardiotoxicity in breast cancer patients treated with anthracyclines and trastuzumab: a real-world observational study
17 May 2025 (08:00 - 12:45)
Organised by: 
About the speaker
Catania (Italy)
7 More presentations in this session
Doctor D. Bursacovschi (Chisinau, MD)
Mr J. Van Fraeyenhove (Turin, IT)
Doctor D. Kutlesic Kurtovic (Nis, RS)
Professor D. Jakovljevic (Newcastle-Upon-Tyne, GB)
Access the full session
The Event
Heart Failure 2025
17 May - 20 May 2025
